NeuroPace, Inc. (NPCE) Financials

NPCE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 98.9 million 84.4 million
Dec. 31, 2025 105.6 million 86.5 million
Sept. 30, 2025 107.3 million 88.7 million
June 30, 2025 106.1 million 86.7 million

NPCE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -6.0 million 2.3 million
Dec. 31, 2025 409000 2.6 million
Sept. 30, 2025 -2.0 million 2.6 million
June 30, 2025 -2.3 million 3.2 million

NPCE Net Income

No data available :(

NPCE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 54.0 million 68.3 million -
Dec. 31, 2025 61.1 million 58.9 million 9.8 million
Sept. 30, 2025 60.0 million 58.7 million 10.4 million
June 30, 2025 62.1 million 58.6 million 12.9 million

NPCE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 33.7 million
Dec. 31, 2025 32.7 million
Sept. 30, 2025 33.1 million
June 30, 2025 32.9 million

NPCE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 117000 7.2 million 16.4 million 11.6 million
Dec. 31, 2025 97000 7.0 million 15.3 million 10.9 million
Sept. 30, 2025 30000 6.6 million 17.2 million 12.6 million
June 30, 2025 168000 6.8 million 18.1 million 12.0 million

NPCE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 22.1 million 4.0 million
Dec. 31, 2025 26.6 million 6.0 million
Sept. 30, 2025 27.4 million 6.2 million
June 30, 2025 23.5 million 5.4 million

NPCE

Price: $15.64

52 week price:
7.56
19.60

Earnings Per Share: -0.65 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 24800

Market Capitalization: 541.4 million

Links: